Aksys Global Markets Europe Ltd
PrimaryBroker profile
Aksys Global Markets Europe Review: Is It Legit and Regulated?
Aksys Global Markets Europe Ltd
FindMyFX score
high risk4.0/10
Contact & regulation
- Official website
- aksysglobalmarkets.eu
- Address
- Vasileos Georgiou A115, 4048 Germasogeia, Limassol, Cyprus
- Contact
- Vasileos Georgiou A115, 4048 Germasogeia, Limassol, Cyprus
- Primary license
- CySEC · Unverified
Missing values mean the information has not been verified or published yet—not that the broker does not provide it.
Quick verdict
Is Aksys Global Markets Europe legit and regulated?
FindMyFX has license records for Aksys Global Markets Europe, but none is currently presented as fully verified. Check each entity, jurisdiction, source, and verification date before depositing.
This is a source-limited research summary, not a safety guarantee or investment recommendation.
Broker-provided company information
Aksys Global Markets Europe Ltd is a Cyprus investment firm authorised by CySEC under licence 456/25.
Professional broker overview
FindMyFX editorial summary
CySEC lists Aksys Global Markets Europe Ltd under licence 456/25, issued April 14, 2025, and approves aksysglobalmarkets.eu as its domain. The permission set covers order reception, execution, dealing on own account, portfolio management, advice and connected foreign-exchange services. Public account-level spreads, leverage and platform information were not available in the inspected regulator entry.
Prepared from reviewed sources for informational purposes. This is not investment advice.
Editorial note: AI-generated draft for FindMyFX staff review; unavailable or unverified fields are left null or empty.
- Operational status
- active
- Broker type
- unknown
- Execution model
- CySEC-authorised investment firm permitted to receive, transmit and execute orders and deal on own account.
- Support hours
- Not verified
Support languages: English
Documented advantages
- CySEC publishes the licence number, licence date, registration number, address, contacts and approved domain.
- The regulator entry specifies investment and ancillary service permissions.
Documented limitations
- The inspected sources did not provide retail account terms, platforms, spreads or leverage.
- The regulator describes foreign-exchange services as connected to investment services, so product scope should be confirmed on the official domain.
Published profile coverage
7 of 8 core information groups currently contain published data. This measures data availability, not broker quality or safety.
Company structure
Legal entities
Registered companies associated with this broker profile.
Markets and instruments
Connected foreign-exchange services
unverified
Financial instruments within the CySEC permission schedule
unverified
Additional broker contacts
General information
Cyprus office
+357 25 254 579
Research sources
Licenses and regulators
CySEC
456/25
Last verified: Not shown
Jurisdiction-specific offerings
CY · other
unverifiedEntity not linked · Leverage not shown
Investor Compensation Fund information should be confirmed from the firm's client documents.
Score components
Regulation and licenses
7.5/10 · 35%A current CySEC entity page provides the licence number, date, permissions and approved domain.
Security and track record
0.0/10 · 20%No authoritative enforcement history or independently verified track-record dataset was reviewed.
Trading conditions
2.5/10 · 15%The regulator confirms service permissions, but account terms and pricing were not available.
Company transparency
7.5/10 · 10%CySEC publishes detailed legal, address, contact, permission and domain information.
Service quality
2.5/10 · 10%Official email and telephone details are in the regulator entry; service outcomes were not independently verified.
Verified user reviews
0.0/10 · 10%No inspectable verified user-review dataset was identified in the official-source review.
Profile update history
Broker profile was published.
2026-07-22
Related regulated broker profiles
These profiles share at least one recorded regulator. This is not a recommendation or equivalence claim.